Logo
x

Search category

Subscribe Now

Approval Prevent

Bayer and Janssen's Xarelto (rivaroxaban) Receive FDA's Approval to Prevent Venous Thromboembolism in Acutely Ill Patients

Bayer and Janssen's Xarelto (rivaroxaban) Receive FDA's Approval to Prevent Venous Thromboembolism in Acutely Ill Patients

  • October 15, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.